Seattle, WA – According to filings with the U.S. Securities and Exchange Commission, Tasso is raising $16,999,976.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Ben Casavant played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Tasso

Tasso’s lead product, Tasso OnDemand, allows people to self-collect blood from the comfort and privacy of their home and mail the samples back to the lab for analysis. By integrating blood tests into the virtual care experience, Tasso expands the amount of data that can be collected to support care delivery and analytics. Headquartered in Seattle, Washington, Tasso is privately held and funded by grants from DARPA, DTRA and the NIH, by investments from Vertical Venture Partners, Techstars, and Cedars Sinai, and by co-development deals with various industry leaders.

To learn more about Tasso, visit http://www.tassoinc.com/

Contact:
Ben Casavant, Chief Executive Officer
206-822-4186
ben@tassoinc.com
https://www.linkedin.com/in/ben-casavant-bb54ab1b/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved